Doyle Mittie bought CGEM
August 7, 2025 · Form 4 insider transaction
Doyle Mittie bought 79,456 shares of Cullinan Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
79,456
Price
$0.00
Total value
N/A
InsiderDoyle Mittie
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateAugust 7, 2025
Filing dateAugust 8, 2025
Shares owned after79,456
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option represents a right to purchase a total of 79,456 shares of the Issuer's common stock, which shall vest as to one-third of the shares underlying the option on each of the first, second and third anniversaries of the grant date of the award, subject to the Reporting Person's continued service as a director on each such vesting date.